The ROR1 inhibitor Strictinin, an ellagitannin isolated from Myrothamnus flabellifolius [12], has demonstrated inhibitory effects on the spheroid-forming capacity of T98G glioblastoma stem-like cells, suggesting its potential in treating this aggressive brain cancer [34]. This evidence concerns the gene ROR1 and glioblastoma.